Skip to main content
. 2018 Sep 3;32(5):1137–1144. doi: 10.21873/invivo.11356

Figure 5. The potential mechanism for KT2-induced inhibition of tumor progression is through blockage of BCL2 apoptosis regulator (BCL2) andpromotion of BCL2-associated X (BAX), caspase-3 cleavage and poly (ADP-ribose) polymerase (PARP) in vivo.

Figure 5